HomeIRLAB-A • STO
add
IRLAB Therapeutics AB
Previous close
kr 2.27
Day range
kr 2.25 - kr 2.40
Year range
kr 2.24 - kr 15.58
Market cap
194.33M SEK
Avg Volume
142.61K
P/E ratio
-
Dividend yield
-
Primary exchange
STO
Market news
Financials
Income Statement
Revenue
Net income
| (SEK) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | 18.85M | 108.69% |
Operating expense | 9.14M | 180.68% |
Net income | -20.23M | 36.09% |
Net profit margin | -107.36 | 69.37% |
Earnings per share | — | — |
EBITDA | -16.13M | 42.84% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (SEK) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 110.13M | 21.85% |
Total assets | 170.55M | 6.40% |
Total liabilities | 116.34M | -4.85% |
Total equity | 54.21M | — |
Shares outstanding | 84.94M | — |
Price to book | 3.55 | — |
Return on assets | -29.91% | — |
Return on capital | -64.99% | — |
Cash Flow
Net change in cash
| (SEK) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | -20.23M | 36.09% |
Cash from operations | 5.26M | 176.84% |
Cash from investing | — | — |
Cash from financing | 57.20M | 6,868.76% |
Net change in cash | 56.49M | 816.03% |
Free cash flow | 7.70M | 27.86% |
About
Founded
2013
Website
Employees
31
